Le Lézard
Classified in: Health, Business
Subject: SHAREHOLDER RIGHTS PLANS

Denis Arsenault Acquires Additional Securities of Jushi Holdings Inc.


BOCA RATON, Fla., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Denis Arsenault (the "Filer"), located at Rue Maria Vieira da Silva Lot #3, Unit U/K, Lagos, Portugal 8600-780, announced today that on January 25, 2021 he disposed of 5,000 subordinate voting shares ("Subordinate Voting Shares") of Jushi Holdings Inc. (the "Issuer") at a price of C$8.80 per share, for an aggregate price of C$44,000 (the "Disposition"). On December 21, 2020, the Issuer completed an acceleration of the expiry date of certain warrants resulting in the issuance of 16,889,728 Subordinate Voting Shares ("Acceleration I"). On January 7, 2021, the Issuer completed a public offering of 6,210,000 Subordinate Voting Shares pursuant to a prospectus supplement to its short form base shelf prospectus dated October 9, 2020 (the "Offering"). The Filer did not participate in the Offering. On January 22, 2021, the Issuer completed a second acceleration of the expiry date of certain warrants resulting in the issuance of 3,703,750 Subordinate Voting Shares ("Acceleration II"). As a result of the Disposition, together with the dilution of the Filer's position in the Issuer as a result of Acceleration I, the Offering and Acceleration II, the Filer's ownership of the Subordinate Voting Shares (as calculated in accordance with National Instrument 62-103 ? The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis) decreased by more than 2%.

Prior to Acceleration I, the Offering, Acceleration II and the Disposition, the Filer held, in the aggregate and on an as-converted basis, approximately 17.1% of the issued and outstanding Subordinate Voting Shares (calculated in accordance with National Instrument 62-103 ? The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis). Following Acceleration I, the Offering, Acceleration II and the completion of the Disposition, the Filer holds 4,000,000 multiple voting shares of the Issuer, 3,350,273 Subordinate Voting Shares, warrants to acquire 6,750,000 multiple voting shares of the Issuer and 6,562,500 warrants to acquire Subordinate Voting Shares, which represent, in the aggregate and on an as-converted basis, approximately 13.1% of the issued and outstanding Subordinate Voting Shares (calculated in accordance with National Instrument 62-103 ? The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis).

This press release is issued pursuant to National Instrument 62-103 ? The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which requires a report to be filed on SEDAR (www.sedar.com) containing additional information with respect to the foregoing matters. A copy of this report may be obtained by contacting Investor Relations, Jushi Holdings Inc., [email protected].

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis-derived assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis ecosystem. For more information, please visit https://www.jushico.com/, https://twitter.com/wearejushi and https://linkedin.com/company/jushi-inc.

Not for distribution to United States newswire services or for dissemination in the United States.

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-281-0247
[email protected]

Media Contact:

Ellen Mellody
MATTIO Communications
570-209-2947
[email protected]



These press releases may also interest you

at 13:24
Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Patty Acomb (D-Minnetonka) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing, as well as the...

at 13:16
Risas Dental & Braces ("Risas"), a dental and braces provider that serves patients in Arizona, Colorado, Texas, and Nevada, has learned of a data security incident that may have involved the protected health information of certain Risas patients....

at 13:15
The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering. As of 2022, the global long-acting drug delivery technologies and services...

at 13:15
The "Global Organoids And Spheroids Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global organoids and spheroids market size was estimated to be USD 0.781 billion in 2023 and is anticipated...

at 13:05
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, today reported...

at 13:00
The following is written by Dr. Steven Gonzales, Chancellor, Maricopa Community Colleges, a member of the American Association of Community Colleges: Arizona, like many states across America, is facing a nurse shortage.  The pandemic has taken a toll...



News published on and distributed by: